Literature DB >> 21953324

Relapsing tumefactive lesion in an adult with medulloblastoma previously treated with chemoradiotherapy and stem cell transplant.

Ali Mahta1, Yan Qu, Denis Nastic, Maria Sundstrom, Ryan Y Kim, Marlon Saria, Sandro Santagata, Santosh Kesari.   

Abstract

Herein, we present an adult case of medulloblastoma who received chemotherapy, radiation therapy and stem cell transplantation, and underwent multiple surgical resections for what were thought to be recurrences; however pathology confirmed a diagnosis of relapsing tumefactive lesions. This phenomenon seems to be a consequence of stem cell transplantation rather than a simple radiation treatment effect.

Entities:  

Mesh：

Year:  2011        PMID： 21953324     DOI： 10.1007/s12253-011-9464-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


  11 in total

1.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

Authors:  P E Ricci; J P Karis; J E Heiserman; E K Fram; A N Bice; B P Drayer
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

2.  3. Utility of PET and 11C-Methionine in the Paediatric Brain Tumors.

Authors: 
Journal:  Clin Positron Imaging       Date:  2000-07

Review 3.  [Positron emission tomography in evaluating the response to treatment of brain tumors, lymphomas and breast cancer].

Authors:  Chariklia Giannopoulou; Christina Fragaki
Journal:  Hell J Nucl Med       Date:  2006 May-Aug       Impact factor: 1.102

4.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.

Authors:  S T Chao; J H Suh; S Raja; S Y Lee; G Barnett
Journal:  Int J Cancer       Date:  2001-06-20       Impact factor: 7.396

5.  CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.

Authors:  H Hertzberg; W J Huk; M A Ueberall; T Langer; W Meier; R Dopfer; M Skalej; H Lackner; U Bode; G Janssen; F Zintl; J D Beck
Journal:  Med Pediatr Oncol       Date:  1997-06

6.  Late cognitive and radiographic changes related to radiotherapy: initial prospective findings.

Authors:  C L Armstrong; J V Hunter; G E Ledakis; B Cohen; E M Tallent; B H Goldstein; Z Tochner; R Lustig; K D Judy; A Pruitt; J E Mollman; E M Stanczak; M Y Jo; T L Than; P Phillips
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

7.  Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study.

Authors:  Pek-Lan Khong; Dora L W Kwong; Godfrey C F Chan; Jonathan S T Sham; Fu-Luk Chan; Gaik-Cheng Ooi
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

8.  White matter changes in children treated for acute lymphoblastic leukemia.

Authors:  E Pääkkö; L Vainionpää; M Lanning; J Laitinen; J Pyhtinen
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

Review 9.  Radiation response of the central nervous system.

Authors:  T E Schultheiss; L E Kun; K K Ang; L C Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

10.  White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

Authors:  Maryam Fouladi; Murali Chintagumpala; Fred H Laningham; David Ashley; Stewart J Kellie; James W Langston; Charles W McCluggage; Shaio Woo; Mehmet Kocak; Kevin Krull; Larry E Kun; Raymond K Mulhern; Amar Gajjar
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
View more
  1 in total

1.  Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Authors:  Matthew A Tremblay; Javier E Villanueva-Meyer; Soonmee Cha; Tarik Tihan; Jeffrey M Gelfand
Journal:  J Neurol Sci       Date:  2017-08-10       Impact factor: 3.181
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.